Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 297 results for "cadila health"

Cadila Healthcare's Q1 results on August 12, 2015

Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2015, inter alia, to consider & approve the unaudited financial results for the quarter ended on June 30, 2015 (Q1). C adila ... Moneycontrol.com, 1 week ago
Cadila Healthcare's AGM on August 12, 2015 Moneycontrol.com, 2 weeks ago
Moneycontrol.com

Cadila Health up 3%, Zydus to market pain killer drug in US

"The Zydus group has received the market authorisation from the US Food and Drug Administration (USFDA) to market Morphine sulphate ER tablets," said the company in its filing to the exchange.
 Money Control1 month ago Cadila gets USFDA nod for Pyridostigmine Bromide  Press Trust of India1 month ago
[x]  

Lupin, Cadila Health, Alembic Pharma up 1-3% on USFDA nods

Lupin and Alembic Pharma both got US FDA nods for antidepressant drug Desvenlafaxine Succinate while Sun Pharma's subsidiary Taro Pharma received approval for anti-allergic tablet Desloratadine.
 Money Control1 month ago
Moneycontrol.com

Cadila Healthcare to delist from Ahmedabad Stock Exchange, will remain listed on BSE and NSE

NEW DELHI: Cadila Healthcare has decided to delist its shares from Ahmedabad Stock Exchange (ASE) in view of non-trading of the company's shares on the exchange for past many years. The company's board, which met today, decided to delist equity ...
 Economic Times1 month ago Cadila to delist from Ahmedabad Stock Exchange  DeshGujarat1 month ago

Zydus to present new scientific data on Lipaglyn in the US

The article below represents a preview only and is not meant for reuse or republishing. Health & Lifestyle United News of India Newswire New Delhi, June 8 -- Healthcare services provider, Zydus Cadila today said the new scientific and clinical ...
 HT Syndication1 month ago

Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia

FREISING, GERMANY--(Marketwired - June 10, 2015) - Pieris Pharmaceuticals, Inc. ( OTCQB: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today the completion of enrollment of healthy ...
 Securities Technology Monitor1 month ago PIERIS PHARMACEUTICALS : Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia  4 Traders1 month ago
[x]  

Employment July 19, 2015

LAMER POWER AND INFRASTRUCTURES PVT LTD Phase-1, Lane -5, IGC Sidco Samba (near Cadila Pharmaceutical) An Associate Company need the following Personals : 1. Turner 01 Post 2. Die fitter 01 Post 3. Welder 03 Post 4. Helper 10 Post 5.
 Daily Excelsior.com1 week ago

Global Statin Market 2015-2019

/PRNewswire/ -- About Statin Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase.
 Franklin Credit Management Corporation4 days ago Research and Markets: Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating  Yahoo! Finance UK and Ireland1 day ago Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating  Individual.com1 day ago Global Statin Market 2015-2019, New Report Launched  Digital Journal1 week ago
[x]  

Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025

/PRNewswire/ -- Prospects for Development, Manufacturing and Business Expansion Sponsored by: Generic Drug Producers - Discover Top Companies' Revenue Prospects Now, Benefiting Your Influence What does the future hold for manufacturers and ...
 TickerTech.com5 days ago
[x]  

Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2015-2025

/PRNewswire/ -- Biosimilar Drugs - Discover Revenue Potential Now, Benefiting Your Authority Do you want to fully understand the sales potentials for biosimilars ? This new analysis provides you with revenue forecasts to 2025 at overall world ...
 Sys-Con Media1 week ago Diabetes Drugs: World Industry, Market, R&D and Sales Forecasts 2015-2025  Wall Street Business Network1 month ago Antibacterial Drugs: World Industry and Market Prospects 2015-2025  Biotechgate1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less